Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: Intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 11, 2013, Pages 5225-5232

  Shimuta, Ken ^a   Unemo, Magnus ^b   Nakayama, Shu Ichi ^a   Morita Ishihara, Tomoko ^a   Dorin, Misato ^a   Kawahata, Takuya ^c   Ohnishi, Makoto ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFIXIME; CEFTRIAXONE; CIPROFLOXACIN; PENICILLIN G; SPECTINOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; JAPAN; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; AZITHROMYCIN; BETA-LACTAM RESISTANCE; CEFIXIME; CEFTRIAXONE; CIPROFLOXACIN; EPIDEMIOLOGICAL MONITORING; FEMALE; GONORRHEA; HUMANS; INCIDENCE; JAPAN; MALE; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; NEISSERIA GONORRHOEAE; PENICILLIN G;

EID: 84885908832     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01295-13     Document Type: Article

References (38)

1. World Health Organization. 2008. Global incidence and prevalence of selected curable sexually transmitted infections -2008. World Health Organization, Geneva, Switzerland. http://www.who.int/reproductivehealth/ publications/rtis/2008-STI-estimates.pdf. Accessed 6 June 2013.
2. Barry PM, Klausner JD. 2009. The use of cephalosporins for gonorrhea: the impending problem of resistance. Expert Opin. Pharmacother. 10: 555-577.
3. Stoltey JE, Barry PM. 2012. The use of cephalosporins for gonorrhea: an update on the rising problem of resistance. Expert Opin. Pharmacother. 13:1411-1420.
4. Deguchi T, Nakane K, Yasuda M, Maeda S. 2010. Emergence and spread of drug resistant Neisseria gonorrhoeae. J. Urol. 184:851-858.
5. Deguchi T, Yasuda M, Yokoi S, Ishida K, Ito M, Ishihara S, Minamidate K, Harada Y, Tei K, Kojima K, Tamaki M, Maeda S. 2003. Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h interval. J. Infect. Chemother. 9:35-39.
6. Tapsall JW, Ndowa F, Lewis DA, Unemo M. 2009. Meeting the public health challenge of multidrug-and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev. Anti Infect. Ther. 7:821-834.
7. Lewis DA. 2010. The gonococcus fights back: is this time a knock out? Sex. Transm. Infect. 86:415-421.
8. Kirkcaldy RD, Ballard RC, Dowell D. 2011. Gonococcal resistance: are cephalosporins next? Curr. Infect. Dis. Rep. 13:196-204.
9. Cole MJ, Unemo M, Hoffmann S, Chisholm SA, Ison CA, van de Laar MJ. 2011. The European gonococcal antimicrobial surveillance programme, 2009. Euro Surveill. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId-19995.
10. Unemo M, Nicholas RA. 2012. Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol. 7:1401-1422.
11. Van de Laar M, Spiteri G. 2012. Increasing trends of gonorrhoea and syphilis and the threat of drug-resistant gonorrhoea in Europe. Euro Surveill. 17(29):pii-20225. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId- 20225.
12. Tanaka M, Koga Y, Nakayama H, Kanayama A, Kobayashi I, Saika T, Iyoda T. 2011. Antibiotic-resistant phenotypes and genotypes of Neisseria gonorrhoeae isolates in Japan: identification of strain clusters with multidrug-resistant phenotypes. Sex. Transm. Dis. 38:871-875.
13. Lewis DA, Sriruttan C, Muller EE, Golparian D, Gumede L, Fick D, de Wet J, Maseko V, Coetzee J, Unemo M. 2013. Phenotypic and genetic characterization of the first two cases of extended-spectrumcephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure. J. Antimicrob. Chemother. 68:1267-1270.
14. Unemo M, Golparian D, Nicholas R, Ohnishi M, Gallay A, Sednaoui P. 2012. High-level cefixime-and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob. Agents Chemother. 56:1273-1280.
15. Unemo M, Golparian D, Syversen G, Vestrheim DF, Moi H. 2010. Two cases of verified clinical failures using internationally recommended firstline cefixime for gonorrhoea treatment, Norway, 2010. Euro Surveill. 15(47):pii-19721. http://www.eurosurveillance.org/ViewArticle.aspx ?ArticleId-19721.
16. Ison CA, Hussey J, Sankar KN, Evans J, Alexander S. 2011. Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. Euro Surveill. 16(14):pii-19833. http://www.eurosurveillance.org/ViewArticle .aspx?ArticleId-19833.
17. Unemo M, Golparian D, Stary A, Eigentler A. 2011. First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria. Euro Surveill. 16(43):pii-19998. http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId-19998.
18. Allen VG, Mitterni L, Seah C, Rebbapragada A, Martin IE, Lee C, Siebert H, Towns L, Melano RG, Low DE. 2013. Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada.JAMA 309:163-170.
19. Yokoi S, Deguchi T, Ozawa T, Yasuda M, Ito S, Kubota Y, Tamaki M, Maeda S. 2007. Threat to cefixime treatment for gonorrhea. Emerg. Infect. Dis. 13:1275-1277.
20. Tapsall J, Read P, Carmody C, Bourne C, Ray S, Limnios A, Sloots T, Whiley D. 2009. Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods. J. Med. Microbiol. 58:683-687.
21. Unemo M, Golparian D, Hestner A. 2011. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010. Euro Surveill. 16(6):pii-19792. http://www.eurosurveillance.org/ ViewArticle.aspx?ArticleId-19792.
22. Unemo M, Golparian D, Potoc?nik M, Jeverica S. 2012. Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011. Euro Surveill. 17(25): pii-20200. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId-20200.
23. Ohnishi M, Golparian D, Shimuta K, Saika T, Hoshina S, Iwasaku K, Nakayama S, Kitawaki J, Unemo M. 2011. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob. Agents Chemother. 55:3538-3545.
24. Ohnishi M, Saika T, Hoshina S, Iwasaku K, Nakayama S, Watanabe H, Kitawaki J. 2011. Ceftriaxone-resistant Neisseria gonorrhoeae, Japan. Emerg. Infect. Dis. 17:148-149.
25. Camara J, Serra J, Ayats J, Bastida T, Carnicer-Pont D, Andreu A, Ardanuy C. 2012. Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. J. Antimicrob. Chemother. 67:1858-1860.
26. World Health Organization (WHO), Department of Reproductive Health and Research. 2012. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae, p 1-36.WHO, Geneva, Switzerland. http://www.who.int/reproductivehealth/publications/rtis/ 9789241503501. Accessed 6 June 2013.
27. Ndowa F, Lusti-Narasimhan M, Unemo M. 2012. The serious threat of multidrug-resistant and untreatable gonorrhoea: the pressing need for global action to control the spread of antimicrobial resistance, and mitigate the impact on sexual and reproductive health. Sex. Transm. Infect. 88:317-318.
28. European Centre for Disease Prevention and Control. 2012. Response plan to control and manage the threat of multidrug-resistant gonorrhoea in Europe, p 1-23. ECDC, Stockholm, Sweden. http://www.ecdc.europa.eu/en/publications/ Publications/1206-ECDC-MDR-gonorrhoea-response-plan .pdf. Accessed 6 June 2013.
29. Centers for Disease Control and Prevention. 2012. Cephalosporinresistant Neisseria gonorrhoeae public health response plan, p 1-43. http://www.cdc.gov/ std/gonorrhea/default.htm. Accessed 6 June 2013.
30. Unemo M, Fasth O, Fredlund H, Limnios A, Tapsall J. 2009. Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. J. Antimicrob. Chemother. 63:1142-1151.
31. Jolley KA. 2001. Multi-locus sequence typing. Methods Mol. Med. 67: 173-186.
32. Martin IMC, Ison CA, Aanensen DM, Fenton KA, Spratt BG. 2004. Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area. J. Infect. Dis. 189:1497-1505.
33. Hunter PR, Gaston MA. 1988. Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity. J. Clin. Microbiol. 26:2465-2466.
34. Ohnishi M, Watanabe Y, Ono E, Takahashi C, Oya H, Kuroki T, Shimuta K, Okazaki N, Nakayama S, Watanabe H. 2010. Spread of a chromosomal cefixime-resistant penA gene among different Neisseria gonorrhoeae lineages. Antimicrob. Agents Chemother. 54:1060-1067.
35. Unemo M, Dillon JA. 2011. Review and international recommendation of methods for typing Neisseria gonorrhoeae isolates and their implications for improved knowledge of gonococcal epidemiology, treatment, and biology. Clin. Microbiol. Rev. 24:447-458.
36. Chisholm SA, Unemo M, Quaye N, Johansson E, Cole MJ, Ison CA, Van de Laar MJW. 2013. Molecular epidemiological typing within the European Gonococcal Antimicrobial Resistance Surveillance Programme reveals predominance of a multidrug-resistant clone. Euro Surveill. 18(3): pii-20358. http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId-20358.
37. Whiley DM, Goire N, Lambert SB, Ray S, Limnios EA, Nissen MD, Sloots TP, Tapsall JW. 2010. Reduced susceptibility to ceftriaxone in Neisseria gonorrhoeae is associated with mutations G542S, P551S and P551L in the gonococcal penicillin-binding protein 2. J. Antimicrob. Chemother. 65:1615-1618.
38. Whiley DM, Limnios EA, Ray S, Sloots TP, Tapsall JW. 2007. Diversity of penA alterations and subtypes in Neisseria gonorrhoeae strains from Sydney, Australia, that are less susceptible to ceftriaxone. Antimicrob. Agents Chemother. 51:3111-3116.